These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Placebo orthodoxy in clinical research. I: Empirical and methodological myths. Freedman B; Weijer C; Glass KC J Law Med Ethics; 1996; 24(3):243-51. PubMed ID: 9069851 [No Abstract] [Full Text] [Related]
25. Risk, Helsinki 2000 and the use of placebo in medical research. Saunders J; Wainwright P Clin Med (Lond); 2003; 3(5):435-9. PubMed ID: 14601942 [TBL] [Abstract][Full Text] [Related]
26. World Medical Association clarifies rules on placebo controlled trials. Ferriman A BMJ; 2001 Oct; 323(7317):825. PubMed ID: 11597960 [No Abstract] [Full Text] [Related]
27. Psychiatry. Are placebo-controlled drug trials ethical? Enserink M Science; 2000 Apr; 288(5465):416. PubMed ID: 10798970 [No Abstract] [Full Text] [Related]
28. Ethics of using controls and placebo in clinical trials. Wilde H; Phaosavasdi S; Pruksapong C; Tannirandorn Y; Taneepanichskul S J Med Assoc Thai; 1999 Jun; 82(6):632-5. PubMed ID: 10443090 [No Abstract] [Full Text] [Related]
29. [Contemporary concept of placebo usage in clinical trials of new drugs]. Orzechowska-Juzwenko K Pol Merkur Lekarski; 2007 Dec; 23(138):473-7. PubMed ID: 18432136 [TBL] [Abstract][Full Text] [Related]
30. Placebo-controlled trials in schizophrenia: are they ethical? Are they necessary? Weijer C Schizophr Res; 1999 Feb; 35(3):211-8; discussion 227-36. PubMed ID: 10093865 [TBL] [Abstract][Full Text] [Related]
31. Ethical Overview of Placebo Control in Psychiatric Research - Concepts and Challenges. Ćurković M; Živković M; Radić K; Vilibić M; Ćelić I; Bagarić D Psychiatr Danub; 2015 Jun; 27(2):118-25. PubMed ID: 26057306 [TBL] [Abstract][Full Text] [Related]
32. Can placebo controls reduce the number of nonresponders in clinical trials? A power-analytic perspective. Leon AC Clin Ther; 2001 Apr; 23(4):596-603. PubMed ID: 11354393 [TBL] [Abstract][Full Text] [Related]
33. Sham procedure versus usual care as the control in clinical trials of devices: which is better? Sutherland ER Proc Am Thorac Soc; 2007 Oct; 4(7):574-6. PubMed ID: 17878472 [TBL] [Abstract][Full Text] [Related]
34. Do we need placebos to evaluate new drugs in children with schizophrenia? Armenteros JL; Mikhail AG Psychopharmacology (Berl); 2002 Jan; 159(2):117-24. PubMed ID: 11862338 [TBL] [Abstract][Full Text] [Related]
35. Placebos in clinical trials of peptic ulcer. ACG Committee on FDA-Related Matters. Smith JL Am J Gastroenterol; 1989 May; 84(5):469-74. PubMed ID: 2719003 [TBL] [Abstract][Full Text] [Related]
36. Is the use of placebo controls ethically permissible in clinical trials of agents intended to reduce fractures in osteoporosis? Brody BA; Dickey N; Ellenberg SS; Heaney RP; Levine RJ; O'Brien RL; Purtilo RB; Weijer C J Bone Miner Res; 2003 Jun; 18(6):1105-9. PubMed ID: 12817764 [TBL] [Abstract][Full Text] [Related]
37. The placebo problem remains. Michels KB Arch Gen Psychiatry; 2000 Apr; 57(4):321-2. PubMed ID: 10768689 [No Abstract] [Full Text] [Related]
38. Debate about placebos points to issue surrounded by many shades of grey. Baer N CMAJ; 1996 Nov; 155(10):1475-6. PubMed ID: 8943938 [TBL] [Abstract][Full Text] [Related]
39. Distinguishing dilemmas in the ethics of placebo-controlled trials. Kovach K Am J Bioeth; 2002; 2(2):32-3. PubMed ID: 12189072 [No Abstract] [Full Text] [Related]
40. Active-controlled versus placebo-controlled trials. Friedman JH Med Health R I; 1999 Jun; 82(6):186. PubMed ID: 10402831 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]